-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, ITINrmzXV/lKtRHxso4xbdUSUM/xv6Sq/a90y9qAsQakgahesv2uB606kOOgCKb1 Jm9lDt9h4RV5OjbaH5z1sg== 0001408617-09-000014.txt : 20090122 0001408617-09-000014.hdr.sgml : 20090122 20090122173029 ACCESSION NUMBER: 0001408617-09-000014 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20090120 FILED AS OF DATE: 20090122 DATE AS OF CHANGE: 20090122 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NPS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000890465 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 870439579 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 550 HILLS DRIVE CITY: BEDMINSTER STATE: NJ ZIP: 07921 BUSINESS PHONE: (908) 450-5300 MAIL ADDRESS: STREET 1: 550 HILLS DRIVE CITY: BEDMINSTER STATE: NJ ZIP: 07921 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Rackear Andrew D. CENTRAL INDEX KEY: 0001408617 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-23272 FILM NUMBER: 09539928 BUSINESS ADDRESS: BUSINESS PHONE: 973-658-8600 MAIL ADDRESS: STREET 1: 550 HILLS DRIVE STREET 2: 3RD FLOOR CITY: BEDMINSTER STATE: NJ ZIP: 07921 FORMER NAME: FORMER CONFORMED NAME: Rackear Andrew D DATE OF NAME CHANGE: 20070801 4 1 edgar.xml PRIMARY DOCUMENT X0303 4 2009-01-20 0000890465 NPS PHARMACEUTICALS INC NPSP 0001408617 Rackear Andrew D. 550 HILLS DRIVE BEDMINSTER NJ 07921 0 1 0 0 SVP, General Counsel & Sec. Stock Option 5.71 2009-01-20 4 A 0 45000 0 A 2019-01-20 Common Stock 45000 45000 D Stock Option 5.71 2009-01-20 4 A 0 73125 0 A 2019-01-20 Common Stock 73125 73125 D Represents options granted to the Reporting Person under the Issuer's 1998 Stock Option Plan. Options vest and become exercisable 25% on the first anniversary of the date of grant and 6.25% every three months thereafter. Represents options granted to the Reporting Person under the Issuer's 1998 Stock Option Plan. Options vest and become exercisable 50% on the second anniversary of the date of grant and 50% on the third anniversary of the date of grant, with the actual number of options vesting on such dates determined based on the performance of the Issuer's common stock relative to the performance of stock comprising a selected market index. Andrew Rackear 2009-01-22 -----END PRIVACY-ENHANCED MESSAGE-----